[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UY28510A1 - Compuestos quimicos - Google Patents

Compuestos quimicos

Info

Publication number
UY28510A1
UY28510A1 UY28510A UY28510A UY28510A1 UY 28510 A1 UY28510 A1 UY 28510A1 UY 28510 A UY28510 A UY 28510A UY 28510 A UY28510 A UY 28510A UY 28510 A1 UY28510 A1 UY 28510A1
Authority
UY
Uruguay
Prior art keywords
chemical compounds
compounds
medicaments
processes
formula
Prior art date
Application number
UY28510A
Other languages
English (en)
Inventor
Neil James Hales
Alexander Louis Breeze
David Timms
Oluyinka Morenike Green
Kenneth Gregory Hull
Haihong Ni
Sheila Irene Hauck
George Byron Mullen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0321509A external-priority patent/GB0321509D0/en
Priority claimed from GB0410527A external-priority patent/GB0410527D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28510A1 publication Critical patent/UY28510A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
    • C04B35/632—Organic additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Ceramic Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Structural Engineering (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen los compuestos de fórmula (1) y sus sales farmacéuticamente aceptables: También se describen los procesos para su preparación, las composiciones farmacéuticas que los contienen, sus usos como medicamentos y su uso en el tratamiento de infecciones bacteriales.
UY28510A 2003-09-13 2004-09-13 Compuestos quimicos UY28510A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0321509A GB0321509D0 (en) 2003-09-13 2003-09-13 Chemical compounds
GB0410527A GB0410527D0 (en) 2004-05-12 2004-05-12 Chemical compounds

Publications (1)

Publication Number Publication Date
UY28510A1 true UY28510A1 (es) 2005-04-29

Family

ID=34315434

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28510A UY28510A1 (es) 2003-09-13 2004-09-13 Compuestos quimicos

Country Status (20)

Country Link
US (1) US7709503B2 (es)
EP (1) EP1664025B1 (es)
JP (1) JP4959329B2 (es)
KR (1) KR20070026318A (es)
AR (1) AR046160A1 (es)
AT (1) ATE373650T1 (es)
AU (1) AU2004272338B2 (es)
BR (1) BRPI0414330A (es)
CA (1) CA2538552A1 (es)
DE (1) DE602004009089T2 (es)
ES (1) ES2291934T3 (es)
HK (1) HK1091491A1 (es)
IL (1) IL174165A0 (es)
IS (1) IS8403A (es)
MX (1) MXPA06002847A (es)
NO (1) NO20061657L (es)
RU (1) RU2006112046A (es)
TW (1) TW200526626A (es)
UY (1) UY28510A1 (es)
WO (1) WO2005026149A1 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861070B1 (fr) * 2003-10-17 2006-01-06 Sanofi Synthelabo Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
CA2586870A1 (en) * 2004-11-10 2006-05-18 Synta Pharmaceuticals Corp. Il-12 modulatory compounds
JP2008530192A (ja) * 2005-02-18 2008-08-07 アストラゼネカ アクチボラグ Ｄｎａジャイレース及びトポイソメラーゼの阻害剤としてのピロール誘導体
KR20070113233A (ko) * 2005-02-18 2007-11-28 아스트라제네카 아베 항균성 피페리딘 유도체
JP2008531673A (ja) * 2005-03-04 2008-08-14 アストラゼネカ アクチボラグ 抗菌活性をもつアゼチジン及びピロールの三環式誘導体
EP2043655A2 (en) 2006-04-25 2009-04-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
WO2008020227A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
WO2008020229A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200819437A (en) * 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
EP1903038A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren
TW200906412A (en) * 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
KR101494734B1 (ko) 2007-10-11 2015-02-26 아스트라제네카 아베 단백질 키나제 ｂ 억제제로서 피롤로[2,3-ｄ]피리미딘 유도체
TWI498115B (zh) 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
JP5524491B2 (ja) * 2008-03-04 2014-06-18 石原産業株式会社 ３−アミノ−２−クロロ−６−トリフルオロメチルピリジンの製造方法
TW201026694A (en) * 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
TW201026695A (en) * 2008-12-12 2010-07-16 Astrazeneca Ab Piperidine compounds and uses thereof-596
EP2370412A1 (en) 2008-12-24 2011-10-05 Syngenta Limited Methods for the preparation of fungicides
TW201102065A (en) 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
TWI625121B (zh) 2009-07-13 2018-06-01 基利科學股份有限公司 調節細胞凋亡信號之激酶的抑制劑
TW201111380A (en) 2009-08-26 2011-04-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
SG178552A1 (en) 2009-08-26 2012-03-29 Cylene Pharmaceuticals Inc Condensed quinolines as protein kinase modulators
EA201200863A1 (ru) 2009-12-14 2013-01-30 Мерк Патент Гмбх Ингибиторы сфингозинкиназы
CA2790277A1 (en) 2010-02-22 2011-08-25 Syngenta Participations Ag Dihydrofuran derivatives as insecticidal compounds
CN104086528A (zh) 2010-07-15 2014-10-08 拜耳知识产权有限责任公司 作为杀虫剂的新杂环化合物
CN103442708B (zh) 2011-04-01 2016-11-09 阿斯利康(瑞典)有限公司 治疗性处理
JP5970537B2 (ja) * 2011-04-19 2016-08-17 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ キナーゼ阻害薬として活性な置換ピリミジニル−ピロール
US20140343049A1 (en) 2011-08-22 2014-11-20 Syngenta Participations Ag Dihydrofuran derivatives as insecticidal compounds
SI2785349T2 (sl) 2011-11-30 2023-01-31 Astrazeneca Ab Kombinirano zdravljenje raka
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
EP2818461A1 (en) 2013-06-26 2014-12-31 Lonza Ltd Method for preparation of 6-trifluoromethylpyridine-3-carboxylic acid derivatives from 4,4,4-trifluoro-3-oxobutanoyl chloride
EP2821399A1 (en) 2013-07-04 2015-01-07 Lonza Ltd Method for preparation of 6-trifluoromethylpyridine-3-carboxylic acid derivatives from 4,4,4-trifluoro-3-oxobutanoyl chloride
WO2015090224A1 (zh) 2013-12-20 2015-06-25 中国人民解放军军事医学科学院毒物药物研究所 新型哌啶氨甲酰类化合物、制备方法及其用途
CA2953019A1 (en) 2014-06-26 2015-12-30 Lonza Ltd Method for preparation of 4-alkoxy-1,1,1-trifluorobut-3-en-2- ones from 1,1,1-trifluoroacetone
JP6621477B2 (ja) * 2014-12-18 2019-12-18 ファイザー・インク ピリミジンおよびトリアジン誘導体ならびにａｘｌ阻害薬としてのそれらの使用
MX2017008417A (es) 2014-12-23 2017-09-28 Gilead Sciences Inc Procedimientos para preparar inhibidores de cinasa 1 reguladora de señal de apoptosis (ask1).
US10399968B2 (en) 2015-09-30 2019-09-03 Daiichi Sankyo Company, Limited Hydroxyalkyl thiadiazole derivatives
DK3798217T3 (da) * 2016-07-28 2023-05-22 Idorsia Pharmaceuticals Ltd Piperidin-cxcr7-receptormodulatorer
DK3538528T3 (da) 2016-11-08 2021-02-15 Bristol Myers Squibb Co Pyrrolamider som alpha v-integrinhæmmere
JP2020511457A (ja) 2017-03-14 2020-04-16 第一三共株式会社 ヒドロキシアルキルチアジアゾール誘導体のｎ−ホスホノキシメチルプロドラッグ
EP3604281A4 (en) 2017-03-24 2020-08-19 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
ES2904645T3 (es) 2017-11-07 2022-04-05 Bristol Myers Squibb Co Derivados de pirrolopirazina como inhibidores de integrina alfa v
ES2976567T3 (es) 2018-01-26 2024-08-05 Idorsia Pharmaceuticals Ltd Formas cristalinas de (1-pirimidin-2-il-ciclopropil)-amida del ácido (3S,4S)-1-ciclopropilmetil-4-{[5-(2,4-difluoro-fenil)-isoxazol-3-carbonil]-amino}-piperidin-3-carboxílico
WO2020048949A1 (en) 2018-09-03 2020-03-12 Univerza V Ljubljani New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria
EA202191349A1 (ru) * 2018-11-15 2021-08-10 Ниппон Синяку Ко., Лтд. 1,3,4-оксадиазолон и фармацевтический препарат
WO2022129327A1 (en) 2020-12-17 2022-06-23 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity
CN116003305A (zh) * 2023-01-31 2023-04-25 康化（上海）新药研发有限公司 一种5-乙基-2-吡咯甲酸的制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL23847A (en) 1964-08-07 1969-02-27 Merck & Co Inc Benzimidazoles useful as antifungals
US3963480A (en) * 1973-04-11 1976-06-15 Sterling Drug Inc. Herbicidal pyrrole-2-carboxamides
US4046775A (en) * 1973-04-11 1977-09-06 Sterling Drug Inc. 4,5-Dihalopyrrole-2-carboxamides
US4791112A (en) * 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US4912109A (en) * 1987-02-02 1990-03-27 Boc, Inc. N-heterocyclic-N-(4-piperidinyl) amides and pharmaceutical compositions and methods employing such compounds
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
FR2766488B1 (fr) 1997-07-23 2000-02-18 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
US6020344A (en) * 1997-08-01 2000-02-01 University Of Florida Enzyme inhibitors and methods of use
JP2003104971A (ja) 1999-08-12 2003-04-09 Wakunaga Pharmaceut Co Ltd 新規アニリド誘導体又はその塩及びこれを含有する医薬
AU2001232809A1 (en) 2000-01-18 2001-07-31 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
DK1251848T3 (da) 2000-01-18 2004-10-18 Vertex Pharma Gyraseinhibitorer og anvendelse deraf
TWI284639B (en) 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
JP2004525069A (ja) 2000-06-15 2004-08-19 ファルマシア・コーポレーション インテグリン受容体アンタゴニストとしてのシクロアルキルアルカン酸
JP2004504397A (ja) * 2000-07-26 2004-02-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー 抗菌活性を有するアミノピペリジンキノリン類およびそれらのアザイソステリックアナログ類
US6964966B2 (en) * 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
DOP2002000386A (es) 2001-05-30 2002-12-15 Warner Lambert Co Agentes antibacterianos
US7491748B2 (en) 2001-08-09 2009-02-17 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
AU2002356689B2 (en) 2001-12-05 2008-05-15 Sanofi-Aventis Deutschland Gmbh Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
AU2003211385A1 (en) 2002-02-28 2003-09-09 Takeda Chemical Industries, Ltd. Azole compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
US7135469B2 (en) 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
JPWO2004089954A1 (ja) 2003-04-08 2006-07-06 大日本住友製薬株式会社 新規なカルバペネム化合物
SE0302116D0 (sv) 2003-07-21 2003-07-21 Astrazeneca Ab Novel compounds
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
US7345043B2 (en) * 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
EP1790636A4 (en) 2004-09-17 2009-07-01 Takeda Pharmaceutical Piperidin derivatives and their use
JP5046950B2 (ja) 2004-10-22 2012-10-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｃ−ｆｍｓキナーゼのインヒビター
DE602005015742D1 (de) 2004-10-22 2009-09-10 Janssen Pharmaceutica Nv Aromatische amide als hemmer der c-fms-kinase
JP2008530192A (ja) 2005-02-18 2008-08-07 アストラゼネカ アクチボラグ Ｄｎａジャイレース及びトポイソメラーゼの阻害剤としてのピロール誘導体
KR20070113233A (ko) 2005-02-18 2007-11-28 아스트라제네카 아베 항균성 피페리딘 유도체
US20080161306A1 (en) 2005-02-18 2008-07-03 Brian Sherer Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
JP2008531673A (ja) 2005-03-04 2008-08-14 アストラゼネカ アクチボラグ 抗菌活性をもつアゼチジン及びピロールの三環式誘導体
WO2006092599A2 (en) 2005-03-04 2006-09-08 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
CA2633563A1 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines

Also Published As

Publication number Publication date
JP4959329B2 (ja) 2012-06-20
JP2007505092A (ja) 2007-03-08
BRPI0414330A (pt) 2006-11-07
DE602004009089T2 (de) 2008-06-12
TW200526626A (en) 2005-08-16
EP1664025B1 (en) 2007-09-19
AR046160A1 (es) 2005-11-30
CA2538552A1 (en) 2005-03-24
AU2004272338A1 (en) 2005-03-24
AU2004272338B2 (en) 2008-06-05
US20060223801A1 (en) 2006-10-05
IL174165A0 (en) 2006-08-01
MXPA06002847A (es) 2006-06-14
EP1664025A1 (en) 2006-06-07
IS8403A (is) 2006-04-07
NO20061657L (no) 2006-06-13
HK1091491A1 (en) 2007-01-19
ATE373650T1 (de) 2007-10-15
DE602004009089D1 (de) 2007-10-31
KR20070026318A (ko) 2007-03-08
WO2005026149A1 (en) 2005-03-24
ES2291934T3 (es) 2008-03-01
US7709503B2 (en) 2010-05-04
RU2006112046A (ru) 2007-11-10

Similar Documents

Publication Publication Date Title
UY28510A1 (es) Compuestos quimicos
UY30759A1 (es) Compuestos quimicos
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
CR11641A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211
UY29384A1 (es) Derivados del ácido2-3s,4r)-4-(((3,4-dicloro-5-metil-1h-pirrol-2-il) carbonil)amino)-1,3-tiazol-5-carboxílico y sus sales, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciónes.
UY31141A1 (es) Compuestos de piperidina y sus usos
UY32315A (es) Compuestos de piperidina y usos de los mismo-596
PA8592301A1 (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
UY27740A1 (es) Nuevos compuestos
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
UY27891A1 (es) Nuevos derivados de glicosido de tiofeno, procedimientos para la preparación de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos.
ECSP045519A (es) Nuevos derivados de quinuclidina-amida
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
UY29182A1 (es) "derivados de bencenosulfonamidas sustituídas, composiciones que las contienen, procedimientos de preparación y aplicaciones"
UY31860A (es) Piridinas de tiazolo como inhibidoras de la adn girasa
CO6351722A2 (es) Derivados heterociclicos de la urea y sus metodos de empleo
UY28271A1 (es) Compuestos químicos
MXPA05012247A (es) Derivados de bencimidazol nuevos.
CR11825A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
UY28366A1 (es) Compuestos químicos
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
UY32674A (es) Derivados heterociclicos de la urea y sus metodos de empleo
SE0302546D0 (sv) New compounds
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150602